Detalhe da pesquisa
1.
Safety of Zilver PTX Drug-Eluting Stent Implantation Following Drug-Coated Balloon Dilation in a Healthy Swine Model.
J Endovasc Ther
; 25(1): 118-126, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29161933
2.
Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
J Vasc Interv Radiol
; 29(7): 1041-1049.e3, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754850
3.
Comparison of Particulate Embolization after Femoral Artery Treatment with IN.PACT Admiral versus Lutonix 035 Paclitaxel-Coated Balloons in Healthy Swine.
J Vasc Interv Radiol
; 27(11): 1676-1685.e2, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641674
4.
Comparison of a Drug-Free Early Programmed Dismantling PDLLA Bioresorbable Scaffold and a Metallic Stent in a Porcine Coronary Artery Model at 3-Year Follow-Up.
J Am Heart Assoc
; 6(6)2017 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600401
5.
Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model.
JACC Cardiovasc Interv
; 8(9): 1248-1260, 2015 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26292590
6.
Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt-chromium XIENCE V stent in a porcine coronary artery model.
Circ Cardiovasc Interv
; 7(3): 330-42, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24895447